AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Monoclonal Antibodies Specific For The Avermectin Antibodies

Detailed Technology Description
None
Others

Tech ID/UC Case

18143/1990-003-0


Related Cases

1990-003-0

*Abstract

Avermectins are a class of potent, broad-spectrum antibiotic and pesticidal substances that are used in a wide array of applications. Extraction and instrumental analysis methods for avermections are complex, lengthy and expensive, making immunoassay a desirable alternative. The University of California, Berkeley, at its Hybridoma Facility has developed monoclonal antibodies that have specificity to the following avermectins:

Aver. B2A2 MAb that recognizes ivermectin, abamectin, but not avermectin A2

Aver. C4D6 MAb with preference for ivermectin

Aver. B11C2 MAb that recognizes ivermectin, abamectin, and avermectin A2

Aver. C1A3 Similar to MAb B2A2

Aver. C5D6 Similar to MAb C4D6

Reference;
Karu et al. Avermectins Detection with Monoclonal Antibodies 1990. ACS Symposium Series No. 442 Immunochemical Methods for Environmental Analysis. pp95-111.

*Principal Investigator

Name: CAROLYN E. CLARKSON

Department:


Name: Alexander Karu

Department:


Name: DOUGLAS J. SCHMIDT

Department:

Country/Region
USA

For more information, please click Here
Mobile Device